Proposed triggers for retiring a living systematic review
暂无分享,去创建一个
E. Akl | Zhen Wang | Lifeng Lin | Joanne Khabsa | I. Riaz | R. Nieuwlaat | Haitao Chu | M. H. Murad | H. Schuenemann | Ibrahim K. El Mikati | Lifeng Lin
[1] E. Akl,et al. A Framework for the Development of Living Practice Guidelines in Health Care , 2022, Annals of Internal Medicine.
[2] T. Ho,et al. Quantifying Absolute Benefit for Adjuvant Treatment Options in Renal Cell Carcinoma: A Living Interactive Systematic Review and Network Meta-analysis. , 2022, Critical reviews in oncology/hematology.
[3] D. Pieper,et al. When is the evidence conclusive? Analysis of systematic reviews for which Cochrane declared that conclusions will not change with further studies , 2022, Research synthesis methods.
[4] Zhen Wang,et al. Thresholds for interpreting the fragility index derived from sample of randomised controlled trials in cardiology: a meta-epidemiologic study , 2022, BMJ Evidence-Based Medicine.
[5] Lara A. Kahale,et al. Extension of the PRISMA 2020 statement for living systematic reviews (LSRs): protocol , 2022, F1000Research.
[6] Neal R Haddaway,et al. Tailored PRISMA 2020 flow diagrams for living systematic reviews: a methodological survey and a proposal , 2022, F1000Research.
[7] E. Akl,et al. Update Alert 3: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19 , 2021, Annals of Internal Medicine.
[8] J. Burns,et al. Methodological challenges for living systematic reviews conducted during the COVID-19 pandemic: A concept paper , 2021, Journal of Clinical Epidemiology.
[9] V. Montori,et al. TEMPORARY REMOVAL: Direct Oral Anticoagulants Compared With Dalteparin for Treatment of Cancer-Associated Thrombosis: A Living, Interactive Systematic Review and Network Meta-analysis. , 2021, Mayo Clinic proceedings.
[10] L. Quintans-Júnior,et al. Efficacy and safety of hydroxychloroquine as pre-and post-exposure prophylaxis and treatment of COVID-19: A systematic review and meta-analysis of blinded, placebo-controlled, randomized clinical trials. , 2021, The Lancet Regional Health - Americas.
[11] J. Warner,et al. Adjuvant Tyrosine Kinase Inhibitors in Renal Cell Carcinoma: A Concluded Living Systematic Review and Meta-Analysis. , 2021, JCO clinical cancer informatics.
[12] G. Guyatt,et al. GRADE guidelines 32: GRADE offers guidance on choosing targets of GRADE certainty of evidence ratings. , 2021, Journal of clinical epidemiology.
[13] T. Ho,et al. A Living, Interactive Systematic Review and Network Meta-analysis of First-line Treatment of Metastatic Renal Cell Carcinoma. , 2021, European urology.
[14] D. Pieper,et al. How to decide whether a systematic review is stable and not in need of updating: Analysis of Cochrane reviews , 2020, Research synthesis methods.
[15] W. Aronow. Faculty Opinions recommendation of Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review. , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[16] B. Rochwerg,et al. Update Alert 2: Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19 , 2020, Annals of Internal Medicine.
[17] G. Guyatt,et al. Drug treatments for covid-19: living systematic review and network meta-analysis , 2020, BMJ.
[18] M. Murad,et al. Efficacy of chloroquine or hydroxychloroquine in COVID-19 patients: a systematic review and meta-analysis , 2020, medRxiv.
[19] E. Akl,et al. Ventilation Techniques and Risk for Transmission of Coronavirus Disease, Including COVID-19 , 2020, Annals of Internal Medicine.
[20] M. Clarke. Partially systematic thoughts on the history of systematic reviews , 2018, Systematic Reviews.
[21] Georgia Salanti,et al. Living systematic reviews: 3. Statistical methods for updating meta-analyses. , 2017, Journal of clinical epidemiology.
[22] Elie A Akl,et al. SERIES: LIVING SYSTEMATIC REVIEWS Living systematic review: 1. Introduction d the why, what, when, and how , 2022 .
[23] Mohammed T Ansari,et al. The GRADE Working Group clarifies the construct of certainty of evidence. , 2017, Journal of clinical epidemiology.
[24] G. Guyatt,et al. When and how to update systematic reviews: consensus and checklist , 2016, British Medical Journal.
[25] G. Guyatt,et al. GRADE guidelines 6. Rating the quality of evidence--imprecision. , 2011, Journal of clinical epidemiology.
[26] Victor M. Montori,et al. Efficacy of Continuous Glucose Monitoring in Improving Glycemic Control and Reducing Hypoglycemia: A Systematic Review and Meta-Analysis of Randomized Trials , 2011, Journal of diabetes science and technology.
[27] K. Thorlund,et al. Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis. , 2008, Journal of clinical epidemiology.
[28] K. Shojania,et al. How Quickly Do Systematic Reviews Go Out of Date? A Survival Analysis , 2007, Annals of Internal Medicine.
[29] G. Guyatt,et al. Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.
[30] S. Yusuf,et al. Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis. , 1997, Controlled clinical trials.